In short. Radiesse explained as a calcium hydroxylapatite (CaHA) collagen stimulator: substance class, mechanism, indication range, duration class, and the side-effect profile that comes with CaHA injections.
Key points
- Radiesse sits in the medium-to-long-duration tier of the volume-restoration ladder.
- It suits patients who want longer-lasting structural lift and contour, particularly in the cheek, chin, and jawline, and who are prepared to accept that correction, if needed, requires waiting for natural breakdown.
- For shorter commitments or first-time facial volume work, HA fillers are usually the safer starting point.
Radiesse is a collagen-stimulating injectable whose active component is calcium hydroxylapatite (CaHA) microspheres suspended in a gel carrier. It sits in a different substance class from both HA fillers and PLLA biostimulators — calcium-based microspheres that provide immediate volume and gradual collagen deposition, eventually broken down by the body over a longer time course.
Substance class: calcium hydroxylapatite (CaHA)
CaHA is a biocompatible material composed of calcium and phosphate ions arranged into microspheres, chemically similar to the mineral component of bone and teeth. The gel carrier provides immediate volume; the CaHA microspheres act as a scaffold for the body’s own collagen production. The microspheres are eventually broken down into calcium and phosphate ions over a longer time course. The substance class is unique — not a filler in the HA sense, not a permanent implant, and not the same mechanism as PLLA.
Common indication range
Radiesse is used for facial volume restoration and contour: cheek and midface volume, chin and jawline contour, mandibular definition, and selected deep dermal placement for skin-thickness work. It is also used off-label in body areas (hands, décolletage) by experienced practitioners. It is not used for superficial lines, lip enhancement, or in areas where very soft HA products are needed — placement matters and the material has a firmer feel than HA gels.
How a treatment session is planned
Treatment begins with assessment of facial anatomy, fat compartment changes, skin thickness, and the patient’s goals. A qualified medical practitioner selects a specific CaHA product within the class, plans conservative placement, and uses review at two to four weeks to evaluate the result. Some practitioners dilute CaHA with sterile saline or lidocaine for skin-quality and superficial work; the dilution protocol is a clinical decision based on the indication.
Expected duration class
CaHA biostimulators are longer-lasting than HA fillers but are not permanent. Duration class is typically in the range of about a year or longer for many patients, depending on the area treated, individual collagen response, and metabolism. The trade-off is that the material is not reversible with hyaluronidase, so correction if needed requires waiting for natural breakdown.
Where Radiesse fits
Radiesse sits in the medium-to-long-duration tier of the volume-restoration ladder. It suits patients who want longer-lasting structural lift and contour, particularly in the cheek, chin, and jawline, and who are prepared to accept that correction, if needed, requires waiting for natural breakdown. For shorter commitments or first-time facial volume work, HA fillers are usually the safer starting point.
Side effects and safety considerations
Common temporary effects include swelling, bruising, and tenderness. The defining safety considerations are: the material is not dissolvable with hyaluronidase (unlike HA fillers), so careful placement matters; the firmer feel makes it unsuitable for superficial placement in many areas; and vascular occlusion risk exists with any deep facial injection and must be managed with the same anatomical awareness as HA fillers.
Who should defer or avoid
Treatment is generally deferred during pregnancy and breastfeeding, in the presence of active infection or inflammation at the planned injection site, and in patients with bleeding disorders or unrealistic expectations. Because the material is not easily reversible, prior filler history matters even more than with HA fillers — permanent fillers or unknown materials in the same area are a contraindication.
Setting realistic expectations
CaHA biostimulators provide immediate volume plus gradual collagen-stimulating effect, with a firmer feel than HA gels. The realistic commitment is a careful first session with a practitioner experienced in CaHA placement, conservative dosing, and a plan for review. Most patients find the result natural-feeling in the right areas; the trade-off is the inability to instantly reverse if something goes wrong.
Seek urgent medical review if
- Severe pain, blanching, or a mottled purple pattern appears during or after treatment — possible vascular occlusion requiring emergency response (CaHA is not reversible with hyaluronidase).
- Visual change of any kind occurs during or after treatment — emergency ophthalmology must be involved without delay.
- Persistent lumps, asymmetry, or nodules develop weeks to months after treatment — assessment, not watchful waiting.
Frequently asked questions
What makes CaHA different from an HA filler?
It is calcium-based microspheres suspended in a gel carrier. The carrier gives immediate volume while the microspheres act as a scaffold for the body’s own collagen production, and the material is eventually broken down into calcium and phosphate ions over a longer time course.
Which areas are treated with CaHA?
Cheek and midface volume, chin and jawline contour, mandibular definition and selected deep dermal placement, with off-label use in the hands and decolletage by experienced practitioners. It is not used for superficial lines or lip enhancement, where its firmer feel is unsuitable.
Can it be dissolved?
No. It is not reversible with hyaluronidase, unlike HA fillers, so correction if needed means waiting for natural breakdown. Some practitioners dilute the material for skin-quality work, but the dilution protocol is a clinical decision based on the indication.
Risks & Limitations
- Burns and blistering if settings do not match the skin.
- Post-inflammatory hyperpigmentation, particularly in darker skin types, which may take months to settle.
- Hypopigmentation (lightening) of treated skin, which can be permanent.
- Scarring, including hypertrophic scarring, which is uncommon but real.
- Infection, including reactivation of herpes simplex after resurfacing.
- Acne or milia flare during recovery.
- Results are incremental and most concerns need several sessions. Melasma may rebound or worsen with aggressive treatment.
When to Seek Care
- Blistering, weeping or broken skin beyond the expected reaction.
- Severe pain that is worsening rather than settling.
- Spreading redness, warmth, pus or fever.
- New darkening or firmness that looks like scarring at the treated area.
- Any change in a treated pigmented lesion — it should be reviewed, not retreated.
References & Further Reading
- American Academy of Dermatology (AAD) — laser and energy device information
- American Society for Laser Medicine & Surgery (ASLMS)
- National Medical Products Administration (NMPA, China) — device registration status
- Cochrane Library — systematic reviews in laser dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.